Sam Sathiamoorthy has built deep expertise in vaccinology, therapeutics and medical devices over the last 15 years in big pharma, biotech start-ups and early stage proof-of-concept environments. She holds a Ph.D. in cellular and molecular biology from the University of Guelph and has vast technical expertise in biopharma, medical devices, GMP manufacturing and FDA, Health Canada and EMA compliance for manufacturing and product release. She is proficient in technical, medical and regulatory writing and has provided regulatory strategy for both IND and CTA submissions.
